MedPath

Effect of Ocular Exercise and Drakshadi Ghrita (Tarpana) with Shatavaryadi Churna in Timira (Simple Hypermetropia)

Phase 2
Conditions
Health Condition 1: H520- Hypermetropia
Registration Number
CTRI/2023/07/055375
Lead Sponsor
ttarakhand Ayurved University Dehradun
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

The patients presenting with classical features of Prathama patalgata Timira after proper screening with the help of Snellenâ??s chart, retinoscopy and computerized auto refractometry will be selected irrespective of sex, occupation, religion etc.

1 Patient having symptoms of Prathama patalgata Timira

2 Patient aged between 12 to 35 years.

3 Patients having simple hypermetropia (+0.5DS to +6.0DS of vision)

Exclusion Criteria

1 Dwitiya, Tritiya and Chaturtha Patalgata Timira

2 Astigmatism

3 Congenital hypermetropia

4 Anomalies like accommodation insufficiency, Presbyopia.

5 Patient with any other anterior & posterior segment ocular pathology like amblyopia, strabismus , cataract, glaucoma, uveitis, retinal pathology..

6 Patient with any systemic disease like Hypertension, Diabetes Mellitus, Tuberculosis.

7 Non vaccinated (covid-19) patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
a. Blurred vision <br/ ><br>b. Eye strain <br/ ><br>c. Watering of eyes <br/ ><br>d. Headache <br/ ><br>e. Snellenâ??s Chart for vision <br/ ><br>f. Ocular examination-a.Retinoscopy (Wet & Dry), b.Auto Refractometry, c. Refraction (Wet & Dry ) <br/ ><br>d. External examination of head ,forehead , Eyebrows, Eyelids, Lid margins, Conjuctiva , Cornea , & Eye movements will be done to rule out any abnormalities. <br/ ><br>Timepoint: 35 days <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
a. Blurred vision <br/ ><br>b. Eye strain <br/ ><br>c. Watering of eyes <br/ ><br>d. Headache <br/ ><br>e. Snellenâ??s Chart for vision <br/ ><br>and Follow Up study will be conducted for 1 month (15 days interval) after completion of treatment.Timepoint: 1 month.
© Copyright 2025. All Rights Reserved by MedPath